Metraipolis › archive › dc_43922acee07a

Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids — Europe PMC PMID:42205749

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42205749
DOI
10.3389/fonc.2026.1742943
License (as archived)
solo-consultazione
Archived
2026-11-02T11:18:08.722Z
SHA-256 of the archived text
e27279b220c66b6b21db02fc3820d0346439ba7e9027aab8a4b8de1751640ee1
Stable URL of this page
https://metraipolis.com/documento/dc_43922acee07a

How to cite

Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids — Europe PMC PMID:42205749 — Europe PMC (en), https://europepmc.org/article/MED/42205749 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43922acee07a (Metraipolis archive dc_43922acee07a, sha256 e27279b220c66b6b21db02fc3820d0346439ba7e9027aab8a4b8de1751640ee1)
BibTeX
@misc{dc43922acee07a,
  title = {Case Report: Personalized treatment in an advanced lung adenocarcinoma patient with EGFR exon 21 L858R mutations based on the patient-derived tumor organoids — Europe PMC PMID:42205749},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42205749},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43922acee07a; sha256 e27279b220c66b6b21db02fc3820d0346439ba7e9027aab8a4b8de1751640ee1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42205749. Agents can read the archived copy with the MCP tool read_document.